Clinical trial reportTargeted oncologyPublished
Vibostolimab Coformulated with Pembrolizumab Plus Chemotherapy as First-Line Therapy for Extensive-Stage Small-Cell Lung Cancer
Regional connection
Verified An author affiliation on the Europe PMC record names Merck & Co. Affiliation source
- Institution
- Merck & Co.
- County
- Montgomery County
Publication record
- Type
- Clinical trial report
- Venue
- Targeted oncology
- Published
- Topic
- Clinical care
- PubMed ID
- 42900351
- Open access
- Yes, open
- Added to directory
- Source checked